首页> 外国专利> TAAR PYRAZOLE CARBOXAMIDE DERIVATIVES AS TAAR MODULATORS FOR USE IN THE TREATMENT OF SEVERAL DISORDERS SUCH AS DEPRESSION DIABETES AND PARKINSON'S DISEASE

TAAR PYRAZOLE CARBOXAMIDE DERIVATIVES AS TAAR MODULATORS FOR USE IN THE TREATMENT OF SEVERAL DISORDERS SUCH AS DEPRESSION DIABETES AND PARKINSON'S DISEASE

机译:TAAR吡唑羧酰胺衍生物作为TAAR调节剂,用于治疗糖尿病和帕金森氏病等数种疾病

摘要

The present invention relates to compounds of formula (I): EMI ID = In this formula, R 1 is Phenyl optionally substituted with one or more substituents independently selected from the group consisting of halogen, lower alkyl, lower cycloalkyl, lower alkoxy, cyano, halogen-substituted lower alkyl, hydroxy-substituted lower alkyl, Lower alkoxy), Pyridin-2, 3 or 4-yl which is optionally substituted with one or more substituents selected from the group consisting of halogen, lower alkyl, lower cycloalkyl, cyano, halogen-substituted lower alkyl, hydroxy-substituted lower alkyl, lower alkoxy, Alkoxy, or hydroxy-substituted lower alkoxy), Pyrimidine-2, 4 or 5-yl, which is optionally substituted by halogen, lower alkyl, lower cycloalkyl, hydroxy-substituted lower alkyl, or halogen- Pyrazin-2-yl, which is optionally substituted with halogen, lower alkyl, lower cycloalkyl, halogen-substituted lower alkyl, hydroxy-substituted lower alkyl or cyano, 2,2-difluorobenzo [d] [1,3] dioxol-5-yl, or Thiazolyl, which is optionally substituted with halogen-substituted lower alkyl; R 2 is hydrogen or lower alkyl; R 3 is hydrogen, amino or lower alkyl; Z is a bond, -CH 2 - or an -O-. It has now been found that the compounds of formula I have excellent affinities for the microamine related receptors (TAAR), in particular TAARl. The compounds may be used in the treatment of depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, psychotic disorders such as schizophrenia, neurological disorders such as Parkinson's disease, neurodegenerative disorders such as Alzheimer's disease, , Migraine, hypertension, substance abuse and metabolic disorders such as eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, energy consumption and assimilation disorders, body temperature homeostatic and dysfunction, circadian rhythm sleep disorders, and cardiovascular disorders Can be used for treatment.
机译:本发明涉及式(I)的化合物:在该式中,R 1 是任选地被一个或多个独立地选自卤素,低级烷基,低级环烷基,低级烷氧基,氰基,卤素取代的低级烷基,羟基取代的低级烷基,低级烷氧基),Pyridin-2、3或4-基,它们任选地被一个或多个选自卤素的取代基取代,低级烷基,低级环烷基,氰基,卤素取代的低级烷基,羟基取代的低级烷基,低级烷氧基,烷氧基或羟基取代的低级烷氧基),嘧啶-2、4或5-基,其任选地被卤素取代,低级烷基,低级环烷基,羟基取代的低级烷基或卤素-吡嗪-2-基,其任选地被卤素,低级烷基,低级环烷基,卤素取代的低级烷基,羟基取代的低级烷基或氰基取代,2 2-二氟苯并[d] [1,3] dioxol-5 -基或噻唑基,其任选地被卤素取代的低级烷基取代; R 2 为氢或低级烷基; R Sup> 3 2 -或-O-。现已发现,式I化合物对微胺相关受体(TAAR),特别是TAAR1具有极好的亲和力。这些化合物可用于治疗抑郁症,焦虑症,躁郁症,注意力缺陷多动障碍(ADHD),与压力有关的疾病,精神分裂症如精神分裂症,神经系统疾病如帕金森氏病,神经退行性疾病如阿尔茨海默氏病, ,偏头痛,高血压,药物滥用和代谢失调,例如饮食失调,糖尿病,糖尿病并发症,肥胖症,血脂异常,能量消耗和同化失调,体温稳态和功能障碍,昼夜节律性睡眠障碍和心血管疾病可用于治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号